Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
47,000
Employees47,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
47,000
Employees47,000

LLY Key Statistics

Market cap
954.61B
Market cap954.61B
Price-Earnings ratio
49.97
Price-Earnings ratio49.97
Dividend yield
0.59%
Dividend yield0.59%
Average volume
3.59M
Average volume3.59M
High today
$1,027.39
High today$1,027.39
Low today
$1,004.00
Low today$1,004.00
Open price
$1,020.51
Open price$1,020.51
Volume
2.50M
Volume2.50M
52 Week high
$1,111.99
52 Week high$1,111.99
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

The current Eli Lilly(LLY) stock price is $1,014.40, with a market capitalization of 954.61B. The stock trades at a price-to-earnings (P/E) ratio of 49.97 and offers a dividend yield of 59.4%.

As of 2025-12-07, Eli Lilly(LLY) stock has fluctuated between $1,004.00 and $1,027.39. The current price stands at $1,014.40, placing the stock +1.0% above today's low and -1.3% off the high.

Eli Lilly(LLY) shares are trading with a volume of 2.5M, against a daily average of 3.59M.

In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,111.99 and a 52-week low of $623.78.

In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,111.99 and a 52-week low of $623.78.

LLY News

Nasdaq 13h
Eli Lilly's Stock Drops as It Slashes the Price of Zepbound: Time to Buy the Dip?

Key Points Eli Lilly's decision to reduce the price of its popular weight loss drug makes more sense than it appears at first. The company still has a robust...

Eli Lilly's Stock Drops as It Slashes the Price of Zepbound: Time to Buy the Dip?
The Motley Fool 2d
Do These 3 Healthcare Stocks Need a Checkup?

These three drugmakers are all well off their recent highs. Is this a sign of opportunity or risk? The pharmaceutical industry is highly competitive, and curre...

Do These 3 Healthcare Stocks Need a Checkup?
Seeking Alpha 2d
Eli Lilly shares fell for seven consecutive sessions

Eli Lilly (LLY) shares clocked seven straight sessions of losses on Friday, as the stock was 0.5% lower at $1,009.15. The pharmaceutical giant lost 8% in the p...

Eli Lilly shares fell for seven consecutive sessions

Analyst ratings

74%

of 31 ratings
Buy
74.2%
Hold
22.6%
Sell
3.2%

More LLY News

The Motley Fool 2d
Meet the Supercharged Growth Stock That Could Join Apple, Nvidia, Microsoft, and Alphabet in the $2 Trillion Club by 2028

Eli Lilly's stock price and market cap are poised to explode with the GLP-1 market. Apple was the first company in history to reach $1 trillion in market value...

Meet the Supercharged Growth Stock That Could Join Apple, Nvidia, Microsoft, and Alphabet in the $2 Trillion Club by 2028
Zacks 2d
Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson and Sanofi

This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herei...

Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson and Sanofi
Nasdaq 2d
With Netflix's 10-for-1 Stock Split Complete, Here Are 3 Growth Stocks to Buy in December That Could Issue Stock Splits in 2026

Key Points Meta Platforms generates high cash flow and can afford to take risks on AI spending. ASML's lithography machines are essential for manufacturing ad...

With Netflix's 10-for-1 Stock Split Complete, Here Are 3 Growth Stocks to Buy in December That Could Issue Stock Splits in 2026
Investor's Business Daily 3d
How Stock Of The Day Genmab Is Leveraging An $8 Billion Deal To Stoke Its Next Chapter

Dow Jones Futures: Small Caps Surge, Eli Lilly Tested; 5 Stocks In Buy Zones 8:43 AM ET Small caps nearly hit all-time highs as the major indexes paused. Eli L...

How Stock Of The Day Genmab Is Leveraging An $8 Billion Deal To Stoke Its Next Chapter
Investor's Business Daily 3d
Dow Jones Futures: Small Caps Surge, Eli Lilly Faces Test; 5 Stocks In Buy Zones

Small Caps Charge, Big Caps Pause; GE Vernova, Genmab, Eli Lilly In Focus 8:32 AM ET Alexis Garcia and Ed Carson walk through Thursday's market action and disc...

Dow Jones Futures: Small Caps Surge, Eli Lilly Faces Test; 5 Stocks In Buy Zones
TipRanks 3d
Eli Lilly price target raised to $1,200 from $1,100 at BMO Capital

BMO Capital raised the firm’s price target on Eli Lilly (LLY) to $1,200 from $1,100 and keeps an Outperform rating on the shares. Following a string of positive...

Nasdaq 3d
How Strong Is AbbVie's Immunology Franchise After Humira's LOE?

AbbVie ABBV is a dominant player in the immunology space, powered by three blockbuster drugs — Skyrizi, Rinvoq and Humira — which together account for nearly ha...

How Strong Is AbbVie's Immunology Franchise After Humira's LOE?

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.